Ironwood Pharmaceuticals, Inc.
Pagina dedicata companiei Ironwood Pharmaceuticals, Inc. listata cu simbolul US.IRWD
Descriere companie[edit | ]
Ironwood Pharmaceuticals, Inc. (http://www.ironwoodpharma.com/) is a gastrointestinal (GI) healthcare company. The Company is focused on the development and commercialization of GI product opportunities in areas of unmet need, including irritable bowel syndrome with constipation (IBS C), and chronic idiopathic constipation (CIC). It operates in human therapeutics business segment. Its product candidate LINZESS (linaclotide) is available to adult men and women suffering from IBS-C or CIC in the United States, and Mexico and to adult men and women suffering from IBS-C in Japan and China. Its linaclotide is available under the trademarked name CONSTELLA to adult men and women suffering from IBS-C or CIC in Canada, and to adult men and women suffering from IBS-C in certain European countries.
Grafic actiuni companie[edit | ]